DZ Bank AG reaffirmed their sell rating on shares of Dragerwerk AG & Co. KGaA (ETR:DRW3) in a research report released on Monday.

A number of other equities research analysts have also recently weighed in on DRW3. Independent Research GmbH set a €85.00 ($98.84) price objective on Dragerwerk AG & Co. KGaA and gave the stock a sell rating in a research note on Monday, July 17th. Warburg Research set a €96.00 ($111.63) price objective on Dragerwerk AG & Co. KGaA and gave the stock a neutral rating in a research note on Thursday, July 27th. Berenberg Bank set a €95.00 ($110.47) price objective on Dragerwerk AG & Co. KGaA and gave the stock a neutral rating in a research note on Thursday, July 27th. Nord/LB set a €108.00 ($125.58) price objective on Dragerwerk AG & Co. KGaA and gave the stock a buy rating in a research note on Friday, July 28th. Finally, Kepler Capital Markets set a €116.00 ($134.88) price objective on Dragerwerk AG & Co. KGaA and gave the stock a buy rating in a research note on Thursday, October 12th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of €84.28 ($97.99).

Shares of Dragerwerk AG & Co. KGaA (DRW3) opened at €70.76 ($82.28) on Monday. Dragerwerk AG & Co. KGaA has a 12 month low of €69.49 ($80.80) and a 12 month high of €107.00 ($124.42).

ILLEGAL ACTIVITY WARNING: This report was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another site, it was stolen and reposted in violation of international copyright & trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2017/11/17/dz-bank-ag-reiterates-sell-rating-for-dragerwerk-ag-co-kgaa-drw3.html.

Dragerwerk AG & Co. KGaA Company Profile

Dragerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including perioperative care, neonatal care, emergency care, critical care, and perinatal care.

Analyst Recommendations for Dragerwerk AG & Co. KGaA (ETR:DRW3)

Receive News & Stock Ratings for Dragerwerk AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dragerwerk AG & Co. KGaA and related stocks with our FREE daily email newsletter.